Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Insulet yesterday reported 3rd-quarter revenues well ahead of expectations on Wall Street, sending the diabetes device maker’s share price up 11% today in early trading despite higher-than-expected losses.
Masimo said yesterday that it and founder & CEO Joe Kiani agreed to retool his employment contract, potentially saving the patient monitoring company as much as $100 million, as it posts 3rd-quarter results that beat expectations and raises its outlook for the rest of the year.
Medrobotics said yesterday that it raised a $25 million equity round for its Flex robotic endoscope system, which is designed to use a flexible robotic endoscope, a range of flexible instruments and a high-definition vision system for use in accessing and visualizing structures in the mouth and throat.